In January the FDA published draft cybersecurity recommendations for marketed medical devices to protect patient safety.

What’s new in this draft FDA guidance document:

Manufacturer’s Responsibilities

This guidance emphasizes that medical device manufacturers should monitor, identify and address cybersecurity vulnerabilities. This draft FDA document highlights that it is essential for device manufacturers to implement comprehensive cybersecurity risk management programs. These programs should focus on addressing the vulnerabilities which could permit the unauthorized access, modification, misuse, or denial of use of information that is stored, accessed, or transferred from a medical device, and could impact patient safety.

Download the FDA Guidance document here: Postmarket Management of Cybersecurity in Medical Devices

You may also be interested in the Pre-market guidance released in 2014

Not sure what to make of these new guidance documents? Talk to our CSV experts about how it may affect your medical device project.

Like it? Share it:

You may also like

What do you need to know about the new FDA guidance on Manufacturing Site Changes?
16 November, 2015

Recently, the FDA drafted this guidance document to help the medical device industry make decisions around manufacturing...

Warning Letter Roundup - December 2016
19 December, 2016

The FDA sends Warning Letters and 483s to companies that significantly violate FDA regulations. We gather those related ...

Are you complying with the new FDA General Wellness Policy for Low Risk Devices?
19 August, 2016

In July 2016, the FDA released Guidance for Industry and FDA Staff – General Wellness: Policy for Low-Risk Devices to cl...